Supraphysiological Doses of L-Thyroxine in the Maintenance Treatment of Prophylaxis-Resistant Affective Disorders

Author： Bauer M.   Berghofer A.   Bschor T.   Baumgartner A.   Kiesslinger U.   Hellweg R.   Adli M.   Baethge C.   Muller-Oerlinghausen B.  

Publisher： Elsevier

ISSN： 0893-133X

Source： Neuropsychopharmacology, Vol.27, Iss.4, 2002-10, pp. : 620-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

THE ROLE OF l-THYROXINE AND HEPATIC REDUCTASE ACTIVITY IN ISONIAZID-INDUCED HEPATOTOXICITY IN RABBITS

By Sarich T.C.   Adams S.P.   Wright J.M.  

Pharmacological Research, Vol. 38, Iss. 3, 1998-01 ,pp. : 199-207

Academic Press

Access to resources Recommend Favorite

Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders

By La Corte R.  

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 527-543

Adis International

Access to resources Recommend Favorite

Aiming at New Targets for the Treatment of Affective Disorders: An Introduction

By  

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1050-1051

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives of use of calcium channels blockers for treatment of affective disorders (experimental data)

By Kozlovsky V.L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 306-307

Elsevier

Access to resources Recommend Favorite

Corticotropin-Releasing Factor Antagonists: Therapeutic Potential in the Treatment of Affective Disorders

By Owens M.J.   Nemeroff C.B.  

CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite